Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
1.
ACS Nano ; 18(16): 10818-10828, 2024 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-38597459

RESUMO

Rapid advancements in immersive communications and artificial intelligence have created a pressing demand for high-performance tactile sensing gloves capable of delivering high sensitivity and a wide sensing range. Unfortunately, existing tactile sensing gloves fall short in terms of user comfort and are ill-suited for underwater applications. To address these limitations, we propose a flexible hand gesture recognition glove (GRG) that contains high-performance micropillar tactile sensors (MPTSs) inspired by the flexible tube foot of a starfish. The as-prepared flexible sensors offer a wide working range (5 Pa to 450 kPa), superfast response time (23 ms), reliable repeatability (∼10000 cycles), and a low limit of detection. Furthermore, these MPTSs are waterproof, which makes them well-suited for underwater applications. By integrating the high-performance MPTSs with a machine learning algorithm, the proposed GRG system achieves intelligent recognition of 16 hand gestures under water, which significantly extends real-time and effective communication capabilities for divers. The GRG system holds tremendous potential for a wide range of applications in the field of underwater communications.

2.
Hum Vaccin Immunother ; 19(2): 2217075, 2023 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-37455405

RESUMO

Two RV vaccines have been licensed in Zhejiang province, China, including the pentavalent RotaTeq (RV5) and the monovalent RV vaccine (RV1). This study aimed to evaluate the cost-effectiveness of RV1 and RV5 to inform the prioritization of provincial immunization program. A decision tree-Markov model was applied to assess the cost-effectiveness of RV1 or RV5 vaccination, compared to no RV vaccination in a 5-year period. The incremental health cost per disability-adjusted life year (DALY) is averted when each kind of RV vaccine included in the immunization program was estimated. It was also compared to the willingness-to-pay (WTP) threshold of 1 time of the Gross Domestic Product (GDP) per capita of Zhejiang province in 2021 (16865.70US$). The uncertainties of these results were assessed through the one-way sensitivity analysis and probabilistic sensitivity analysis. In the base-case scenario, RV5 was the least costly RV vaccine with a cost-effectiveness ratio of 510 US$ per DALY averted. The other RV1 vaccines provided equivalent benefits but at higher costs, with a cost-effectiveness ratio of 4600 US$ per DALY averted. Compared to no vaccination, the probabilities of being cost-effective were 72.3% for RV1 and 88.4% for RV5, at a WTP threshold of 1 time of the GDP per capita. An RV vaccination program using any of the two China-licensed RV vaccines compared to no vaccination would avert 30-70% of outpatient visits, hospitalizations, and deaths from RVGE. RV5 was currently estimated to be the most cost-effective.


Assuntos
Infecções por Rotavirus , Vacinas contra Rotavirus , Humanos , Lactente , Infecções por Rotavirus/prevenção & controle , Análise de Custo-Efetividade , Análise Custo-Benefício , Programas de Imunização , China , Árvores de Decisões
3.
Aging (Albany NY) ; 15(5): 1685-1698, 2023 03 13.
Artigo em Inglês | MEDLINE | ID: mdl-36917087

RESUMO

The cervical cancer tumor microenvironment is a diverse and complex ecosystem. Tumor-immune cell infiltration (ICI) may influence immune escape and immunotherapeutic responses. However, the relationship between immune cell infiltrations, immune escape, and immunotherapy in cervical cancer has not been fully clarified. Here, Principal component analysis (PCA) and Tumor immune dysfunction and exclusion (TIDE) were applied to calculate individual ICI scores and probabilities of immune escape, respectively. Through the IMvigor210 and the Cancer Immunome Atlas (TCIA) datasets, we validated the different responses to immunotherapy in two subgroups of patients. Furthermore, therapeutic benefits of different patients were predicted by the pRRophetic package. We found that patients with high ICI scores were prone to immune escape due to the activated JAK-STAT signaling pathway, along with lower CD8+ T cells. High ICI scores patients could benefit more from anti-PD-L1 immunotherapy, and individuals with low scores may be better candidates for the anti-CTLA-4 treatment. Combinations of immunotherapies with targeted inhibitors may improve clinical efficacy and reduce the risk of tumor recurrence. The ICI model not only helps us enhance the cognition of immune escape, but also guides the application of immunotherapy in cervical cancer patients.


Assuntos
Neoplasias do Colo do Útero , Humanos , Feminino , Neoplasias do Colo do Útero/terapia , Ecossistema , Recidiva Local de Neoplasia , Imunoterapia , Linfócitos T CD8-Positivos , Microambiente Tumoral
4.
Int J Immunopathol Pharmacol ; 37: 3946320231161174, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36848930

RESUMO

Apigenin is a kind of flavonoid with many beneficial biological effects. It not only has direct cytotoxicity to tumor cells, but also can boost the antitumor effect of immune cells by modulating immune system. The purpose of this study was to investigate the proliferation of NK cells treated with apigenin and its cytotoxicity to pancreatic cancer cells in vitro, and explore its potential molecular mechanism. In this study, the effect of apigenin on NK cell proliferation and killing pancreatic cancer cells were measured by CCK-8 assay. Perforin, granzyme B (Gran B), CD107a, and NKG2D expressions of NK cells induced with apigenin were detected by flow cytometry (FCM). The mRNA expression of Bcl-2, Bax and protein expression of Bcl-2, Bax, p-ERK, and p-JNK in NK cells were evaluated by qRT-PCR and western blotting analysis, respectively. The results showed that appropriate concentration of apigenin could significantly promote the proliferation of NK cells in vitro and enhance the killing activity of NK cells against pancreatic cancer cells. The expressions of surface antigen NKG2D and intracellular antigen perforin and Gran B of NK cells were upregulated after treating with apigenin. Bcl-2 mRNA expression was increased, while Bax mRNA expression was decreased. Similarly, the expression of Bcl-2, p-JNK, and p-ERK protein was upregulated, and the expression of Bax protein was downregulated. The molecular mechanism of the immunopotentiation effects of apigenin may be that it up-regulates Bcl-2 and down-regulates Bax expression at the gene and protein levels to facilitate NK cell proliferation, and up-regulates the expression of perforin, Gran B, and NKG2D through the activation of JNK and ERK pathways to enhance NK cell cytotoxicity.


Assuntos
Apigenina , Neoplasias Pancreáticas , Humanos , Apigenina/farmacologia , Proteína X Associada a bcl-2 , Proliferação de Células , Subfamília K de Receptores Semelhantes a Lectina de Células NK , Neoplasias Pancreáticas/tratamento farmacológico , Perforina , Proteínas Proto-Oncogênicas c-bcl-2 , RNA Mensageiro , Células T Matadoras Naturais/imunologia , Neoplasias Pancreáticas
6.
Hum Vaccin Immunother ; 18(7): 2152256, 2022 12 30.
Artigo em Inglês | MEDLINE | ID: mdl-36484114

RESUMO

The safety profile of the 9-valent human papillomavirus vaccine (9vHPV) was evaluated based on the reporting rate of adverse events following immunization (AEFI) obtained from the passive surveillance data in Zhejiang. The 9vHPV AEFI reports in Zhejiang were collected and reviewed from the National Adverse Event Following Immunization Surveillance System (NAEFISS) from 2019 to 2021. Reporting rates of AEFI were analyzed under multiple aspects, including age, city, number of vaccinations, AEFI categories, and diagnosis categories. This study used the reporting odds ratio (ROR) for anomalous signal assessment. The NAEFISS collected 331 AEFI reports after administering 1,064,851 doses of 9vHPV, with a crude AEFI rate of 3.12/10,000 doses. The third dose had the highest reporting rate of minor vaccine-related reaction (n = 80, 3.06 per 10,000), followed by the first dose (n = 134, 2.98 per 10,000), and second dose (n = 76, 2.15 per 10,000). Fever/redness/induration was the most common minor adverse event (281 records, 2.64/10,000 doses). Nine cases of urticaria, ten cases of allergic rash, and ten cases of syncope were recorded. This study found a positive signal association between 9vHPV immunization and adverse events such as syncope, encephalitis, sterile abscess, and urticaria. This study did not identify any new emerging safety concerns. In the future, more research is needed to validate and further explore adverse reactions associated with 9vHPV.


Assuntos
Vacinas contra Papillomavirus , Urticária , Humanos , Lactente , Vacinas contra Papillomavirus/efeitos adversos , Papillomavirus Humano , Sistemas de Notificação de Reações Adversas a Medicamentos , Vacinação/efeitos adversos , Imunização/efeitos adversos , Urticária/induzido quimicamente , Síncope/induzido quimicamente , China
7.
Front Surg ; 9: 973106, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36132202

RESUMO

Background: Inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS) is a rare subtype of follicular dendritic cell sarcoma (FDCS) that is mainly located in the liver and spleen (1). Splenic IPT-like FDCS is a rare low-grade malignancy with non-specific clinical manifestations and laboratory findings. Herein, we reported the pathological and imaging features of a case with splenic IPT-like FDCS. Case presentation: A 57-year-old woman was found to have a mass in the spleen during a physical examination and was hospitalized for further treatment. Her laboratory results were within the normal range. Unenhanced and contrast-enhanced computed tomography scans of the whole abdomen showed a round mass in the spleen, with a diameter of about 5 cm. After further examination with enhanced MRI, a provisional diagnosis of splenic hemangioma or splenic hamartoma was made. The patient underwent splenectomy, and the pathological diagnosis was splenic IPT-like FDCS. No tumor recurrence or metastasis was found during the 1-year follow-up after the operation. Conclusions: Herein, we reported a case of splenic IPT-like FDCS. Although the clinical examination and laboratory examination lack specificity, the imaging of this case showed that the lesion was a solid mass with progressive enhancement, and the central scar showed the characteristics of delayed enhancement, which facilitated the diagnosis.

8.
Phys Rev E ; 105(6-1): 064116, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35854510

RESUMO

We study the explosive percolation with k-mer random sequential adsorption (RSA) process. We consider both the Achlioptas process (AP) and the inverse Achlioptas process (IAP), in which giant cluster formation is prohibited and accelerated, respectively. By employing finite-size scaling analysis, we confirm that the percolation transitions are continuous, and thus we calculate the percolation threshold and critical exponents. This allows us to determine the universality class of the k-mer explosive percolation transition. Interestingly, the numerical simulation suggests that the universality class of the explosive percolation transition with the AP alters when the k-mer size changes. In contrast, the universality class of the transition with the IAP is independent of k, but it differs from that of the RSA without the IAP.

9.
Hum Vaccin Immunother ; 18(1): 2035141, 2022 12 31.
Artigo em Inglês | MEDLINE | ID: mdl-35240930

RESUMO

OBJECTIVES: To evaluate the safety of 13-valent pneumococcal conjugate vaccine (PCV13) after its licensure. METHODS: Review and describe the AEFI reported to national adverse event following immunization surveillance system (NAEFISS) in Zhejiang province from 2017 to 2020. Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, and reaction categories. The data mining algorithm used in this study was reporting odds ratio (ROR). A value of ROR-1.96SE >1 (standard error [SE]) was considered as the positive signal. RESULTS: NAEFISS received 3332 AEFI cases following PCV13, with a reporting rate of 17.58/10000 doses. Of the reported AEFI, 652 were serious AEFI cases and the reporting rate was 3.44 for serious AEFI. The reporting rate of fever was the highest among all the clinical diagnosis (7.39/10000 doses). The positive signals were obtained for injection site reaction (ROR-1.96SE: 1.55), hypotonic hyporesponsive episode (HHE) (ROR-1.96SE: 1.62) and febrile seizure (ROR-1.96SE: 1.52). CONCLUSION: The present results supported previous observations that the PCV13 administered as the four-dose schedule was generally well tolerated in Chinese infants as we did not identify any new/unexpected safety concern from the NAEFISS during a four-year time period.


Assuntos
Imunização , Vacinação , Sistemas de Notificação de Reações Adversas a Medicamentos , China/epidemiologia , Humanos , Imunização/efeitos adversos , Lactente , Vacinação/efeitos adversos , Vacinas Conjugadas
10.
Vaccines (Basel) ; 10(2)2022 Feb 17.
Artigo em Inglês | MEDLINE | ID: mdl-35214777

RESUMO

OBJECTIVES: One dose of Sabin-strains inactivated polio vaccine (IPV) was introduced into the Chinese immunization program on 1 May 2016. This study aimed to evaluate the safety of Sabin-strains IPV and provide a comparison with conventional Salk-strains IPV. METHODS: Adverse events following immunization (AEFI) records associated with Sabin-strains IPV and Salk-strains IPV were extracted from the national AEFI surveillance system (NAEFISS) from 1 May 2016 to 31 December 2020. The vaccination information on Sabin-strains IPV and Salk-strains IPV during the same period was obtained from the Zhejiang provincial immunization information system. Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, and reaction categories and were compared between Sabin-strains IPV and Salk-strains IPV. RESULTS: In total, 3,861,758 doses of Sabin-strains IPV and 1,018,604 doses of Salk-strains IPV were administered during the study period. The overall AEFI reporting rate for Sabin-strains IPV (3.96/10,000 doses) was significantly lower than that for Salk-strains IPV (5.03/10,000 doses) due to the reporting rate of the minor vaccine product-related reaction following Sabin-strains IPV was significantly lower than that for Salk-strains IPV (2.76/10,000 doses vs. 3.83/10,000 doses). The most frequently reported symptoms/signs were fever, induration/swelling, and rash/urticaria. The most frequently reported serious AEFI with a causal relationship was febrile convulsion, with the reporting rates of 0.10/10,000 doses for Sabin-strains IPV and 0.08/10,000 doses for Salk-strains IPV. No significant difference was found in the reporting rates of the other serious AEFI between the two types of IPV. CONCLUSION: Most of the AEFI following Sabin-strains IPV and Salk-strains IPV were mild and common adverse reactions. The reporting rate of serious AEFI was not significantly different between Sabin-strains IPV and Salk-strains IPV. Sabin-strains IPV had a favorable safety profile and could be widely used.

11.
Hum Vaccin Immunother ; 18(1): 2021711, 2022 12 31.
Artigo em Inglês | MEDLINE | ID: mdl-35108152

RESUMO

OBJECTIVES: The aim of this study is to describe the reporting rate of adverse events following immunization (AEFI) with pentavalent vaccine: diphtheria-pertussis-tetanus-poliomyelitis-Haemophilus influenzae type b (DPT-IPV/Hib), and to determine whether the reporting rate of AEFI following DPT-IPV/Hib was higher than the average level of the other vaccines. METHODS: Review and describe the AEFI reported to national adverse event following immunization surveillance system (NAEFISS) in Zhejiang province from 2015 to 2020. Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, and reaction categories. The data mining algorithm used in this study was reporting odds ratio (ROR). A value of ROR­1.96SE >1 (standard error [SE]) was considered as positive signal. RESULTS: NAEFISS received 5726 AEFI reports following DTP-IPV/Hib, with a reporting rate of 20.01/10000 doses. Of the reported AEFI, 202 were serious vaccine product-related reactions, including two cases of anaphylactic shock, five cases of Guillain Barre Syndrome (GBS) and two cases of acute disseminated encephalomyelitis. The reporting rate of fever/redness/induration was the highest among all the clinical diagnosis (14.97/10000 doses). The positive signals were obtained for allergic rash (ROR-1.96SE: 1.36), febrile convulsion (ROR-1.96SE: 1.32) and GBS (ROR-1.96SE: 1.16). CONCLUSION: The present findings bolstered that the DTP-IPV/Hib administered as the four-dose schedule was generally well tolerated in Chinese infants as we did not identify any new/unexpected safety concern from the NAEFISS during a six-year timespan.


Assuntos
Vacinas Anti-Haemophilus , Haemophilus influenzae tipo b , Poliomielite , Vacina contra Difteria, Tétano e Coqueluche , Vacinas contra Hepatite B , Humanos , Imunização/efeitos adversos , Esquemas de Imunização , Lactente , Poliomielite/etiologia , Vacina Antipólio de Vírus Inativado/efeitos adversos , Vacinação , Vacinas Combinadas
12.
Membranes (Basel) ; 11(11)2021 Oct 27.
Artigo em Inglês | MEDLINE | ID: mdl-34832049

RESUMO

Herein, a novel form of bicomponent nanofiber membrane containing stereo-complex polylactic acid (SC-PLA) was successfully produced by the side-by-side electrospinning of Poly (L-lactic acid) (PLLA) and Poly (D-lactic acid) (PDLA). We demonstrate that through these environmentally sustainable materials, highly efficient nanofiber assemblies for filtration can be constructed at very low basis weight. The physical and morphological structure, crystalline structure, hydrophobicity, porous structure, and filtration performance of the fibrous membranes were thoroughly characterized. It was shown that the fabricated polylactic acid (PLA) side-by-side fiber membrane had the advantages of excellent hydrophobicity, small average pore size, high porosity, high filtration efficiency, low pressure drop as well as superior air permeability. At the very low basis weight of 1.1 g/m2, the filtration efficiency and pressure drop of the prepared side-by-side membrane reached 96.2% and 30 Pa, respectively. Overall, this biomass-based, biodegradable filtration material has the potential to replace the fossil fuel-based polypropylene commercial meltblown materials for the design and development in filtration, separation, biomedical, personal protection and other fields.

13.
Hum Vaccin Immunother ; 17(12): 5447-5453, 2021 Dec 02.
Artigo em Inglês | MEDLINE | ID: mdl-34613883

RESUMO

OBJECTIVES: To evaluate the reporting rate of adverse events following immunization (AEFI) of the quadrivalent human papillomavirus vaccine (4vHPV) and to compare the reporting rate of AEFI following 4vHPV with those following other vaccines. METHODS: Review and describe the AEFI reported to national adverse event following immunization surveillance system (NAEFISS) in Zhejiang province from 2018 to 2020. Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, and reaction categories. The data mining algorithm used in this study was reporting odds ratio (ROR). A value of ROR­1.96SE >1 (standard error [SE]) was considered as positive signal. RESULTS: NAEFISS received 238 reports after receipt of 4vHPV and 899,282 doses of 4vHPV were administered during the study period, with a crude reporting rate of 2.7/10000 doses. Fever/redness/induration (101 reports) was the most common event reported (1.12/10000 doses). Two cases of anaphylactic shock, three cases of Guillain Barre Syndrome and two cases of acute disseminated encephalomyelitis were reported. ROR showed positive signals for seizure (ROR­1.96SE: 2.1), syncope (ROR­1.96SE: 1.3), allergic rash (ROR­1.96SE: 1.6) and headache (ROR­1.96SE: 2.1). CONCLUSION: The present analysis did not identify new/unexpected safety concerns. Further epidemiological studies are required to systematically validate the data provided by NAEFISS.


Assuntos
Síndrome de Guillain-Barré , Vacinas contra Papillomavirus , Sistemas de Notificação de Reações Adversas a Medicamentos , Síndrome de Guillain-Barré/induzido quimicamente , Humanos , Imunização/efeitos adversos , Vacinas contra Papillomavirus/efeitos adversos , Vacinação/efeitos adversos
14.
Hum Vaccin Immunother ; 17(10): 3823-3830, 2021 10 03.
Artigo em Inglês | MEDLINE | ID: mdl-34170800

RESUMO

Objectives: This study summarizes passive surveillance data for adverse events following immunization (AEFI) in Zhejiang province.Methods: The AEFI reports and number of doses on all vaccines used were extracted from the national AEFI surveillance system and the immunization information system of Zhejiang province (ZJIIS). Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, vaccine types, and reaction categories.Results: A total of 13,079 AEFI records were reported and 23,091,401 vaccine doses were administered, with a reporting rate of 56.64/100,000 doses for AEFI. The highest reporting rate of AEFI was observed among the infants <1 year of age (108.61/100,000 doses) and the lowest rate was observed among recipients aged ≥60 years. Most of the AEFI reports were vaccine product-related reactions (48.81/100,000 doses), and the lowest was vaccination errors (0.02/100,000 doses). The most frequently reported individual vaccine was DTP and Hib combined vaccine, with a reporting rate of 426.62/100,000 doses. The most frequently reported AEFI was fever/redness/induration (48.82/100,000 doses).Conclusion: Our findings illustrated the high level of vaccine safety since the majority of those reported were not serious, or coincidentally associated with vaccination. Furthermore, the national AEFI surveillance system should be continuously used as a surveillance tool for monitoring of AEFI.


Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos , Imunização , China/epidemiologia , Estudos Transversais , Humanos , Lactente , Pessoa de Meia-Idade , Estudos Retrospectivos , Vacinação/efeitos adversos , Vacinas Conjugadas
15.
Hum Vaccin Immunother ; 17(9): 3034-3041, 2021 09 02.
Artigo em Inglês | MEDLINE | ID: mdl-33825657

RESUMO

BACKGROUND: We compared results from household data sources to medical record sources by using data from a vaccination coverage survey. METHODS: Vaccination coverage (VC) was calculated based on parental recall, household vaccination booklet, and Zhejiang provincial immunization information system (ZJIIS). We evaluated the accuracy of VC based on household sources (vaccination booklet and recall) assuming the medical record was accurate. Concordance, sensitivity, specificity, positive predictive value, and negative predictive value were estimated as well as the Kappa statistic was also used to evaluate the agreement between data sources. RESULTS: Among the 1,800 children identified in the household survey, all were registered in ZJIIS. VC estimated using the vaccination booklet alone was substantially lower than that based on medical records (net bias 3.4-16.7% in different age groups). VC based on parental recall ranged from 2.5% below (among children aged 1 year) to 16.7% points above (among children aged 6 years) than those based on medical records. Concordance was lowest for card estimates (32.5-45.5%). Sensitivity was <60% for all household sources, except for recall source. Specificity was lowest for recall estimates (14.5-42.6%). Positive predictive value was >75%, while negative predictive value was <50%, for all household sources. Kappa statistics generally indicated poor agreement between household and medical record sources. CONCLUSIONS: Household-retained vaccination booklets and parental recall were insufficient sources for evaluating the VC. Our findings emphasized the importance of taking interventions to make the vaccination booklet more consistent with the records from medical resource.


Assuntos
Folhetos , Cobertura Vacinal , Cuidadores , Criança , Humanos , Imunização , Lactente , Vacinação
16.
Onco Targets Ther ; 13: 2833-2842, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32308417

RESUMO

INTRODUCTION: Pancreatic cancer (PC) is one of the leading causes of cancer, with the lowest 5-year survival rate of all cancer types. Given the fast metastasis of PC and its resistance to surgery, radiotherapy, chemotherapy, and combinations thereof, it is imperative to develop more effective anti-PC drugs. Phillygenin (PHI) has been reported to exert anti-cancer, anti-bacterial, and anti-inflammatory properties. However, the mechanism of PHI in the development of PC is still unclear. METHODS: The cytotoxicity of PHI in pancreatic cancer cells was evaluated by MTT assay, and clonogenic assay was used to test the anti-proliferation of PHI. The pro-apoptotic effect of PHI was detected by flow cytometry analysis. The changes of epithelial-mesenchymal transition (EMT) in pancreatic cancer cells treated with PHI were determined by Western blot. Transwell assay was used to test the migration and invasion of PC cells after treatment with PHI. Molecular docking was used to predict the potential binding site of candidate target with PHI. RESULTS: PHI could inhibit the proliferation, migration, and EMT of PC cells (PANC-1 and SW1990) and induce its apoptosis. Analysis of the Cancer Genome Atlas database indicated that elevated MELK levels correlated with poor overall survival (OS) and disease-free survival (DFS) of PC patients. In addition, molecular modeling showed that PHI may potentially target the catalytic domain of maternal embryonic leucine zipper kinase (MELK). Overexpression of MELK muted the anti-PC effects of PHI. CONCLUSION: PHI holds promise as a potent candidate drug for the treatment of PC via targeted MELK.

17.
Polymers (Basel) ; 12(3)2020 Mar 06.
Artigo em Inglês | MEDLINE | ID: mdl-32155928

RESUMO

Polypropylene (PP) fibers are employed commonly as the raw material of technical textiles (nonwovens), and the research focuses on fine-denier fibers and their functionalities. In this work, antibacterial PP masterbatches with different dosage (1-5 wt.%) of nano-ZnO particles as the antibacterial agent were prepared via a twin-screw extruder. The as-prepared PP masterbatches were electrospun on a home-made electrospinning device to afford ultra-fine PP fibers. The morphologies of as-spun ultrathin PP fibers with 16 µm of average diameter were observed by SEM. The structure and element distribution were characterized by means of energy-dispersive spectroscopy (EDS) and Fourier-transfer infrared spectroscopy (FTIR), respectively. There was some zinc obviously distributed on the surface when a dosage of ZnO more than 1 wt.% was used, which contributed to the antibacterial activity. The crystallinity of PP fibers was not affected strongly by the dosage of ZnO based on the differential scanning calorimetry (DSC) heating curves, while thermal decomposition improved with the increase in ZnO content, and the mechanical strength decreased predictably with the increase in inorganic ZnO content.

18.
Polymers (Basel) ; 12(1)2020 Jan 09.
Artigo em Inglês | MEDLINE | ID: mdl-31936469

RESUMO

Development of a novel filter material is urgently required for replacing the high-cost flue gas purification technology in the simultaneous removal of both fine dust and Nitrogen oxides (NOx). In this study; polyphenylene sulfide (PPS) needle-punching fibrous felts (NPFF) were employed as the filter material to remove the fine dust; and in the meanwhile; Mn and Ce oxides were loaded onto the PPS NPFF as the catalyst for selective catalytic reduction of NOx with NH3. Two different pretreatment methods; i.e., sodium alginate (SA) deposition and plasma treatment; were employed to modify the PPS NPFF before the traditional impregnation and thermal treatment processes during the catalyst loading. The results showed that these two pretreatment methods both afforded the PPS NPFF with the enhanced loading rate and stability of Mn/Ce oxides compared to those without any pretreatments; which were significantly beneficial for the denitration application. Moreover; we found that both SA deposition and plasma pre-treated samples presented excellent dust-removal properties; and the filtration efficiency could reach 100% when the particle size of the fine particulates was above 4 µm. This study demonstrated that our Mn/Ce oxides decorated PPS NPFF have great potential to be applied in the fuel gas purification field; due to their stable structure; handling convenience; and excellent filtration efficiency; as well as high denitration performance.

19.
Biomed Res Int ; 2019: 3295781, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31828099

RESUMO

The group-specific component (GC) gene, one of the vitamin D pathway genes, seems to play an important role in cancer development. A population-based breast cancer study including 818 cases and 935 controls in a Chinese population was carried out to evaluate the potential associations of four polymorphisms (rs16847024, rs17467825, rs2298850, and rs3755967) in the GC gene with risk of breast cancer. We detected three SNPs with statistically significant effects on breast cancer development after adjusting for age, menopausal status, body mass index (BMI), family history of breast cancer, income, waist circumference, and education (rs17467825: adjusted OR = 0.80, 95% CI = 0.65-0.99; rs2298850: adjusted OR = 0.80, 95% CI = 0.65-0.98; rs3755967: adjusted OR = 0.80, 95% CI = 0.65-0.98). Stratified analysis found that when an individual had a waist circumference <80 cm, rs17467825, rs2298850, and rs3755967 could markedly reduce the risk of breast cancer. Significant interactions between polymorphisms of rs2298850 and rs3755967 and waist circumference were also observed for breast cancer risk. Combined analysis revealed a significant association among the allele numbers of protective effects with decreased breast cancer risk (P trend=0.043). These results indicated that, in the GC gene, genetic mutations might be related to breast cancer susceptibility in Chinese women.


Assuntos
Povo Asiático/genética , Neoplasias da Mama/genética , Predisposição Genética para Doença/genética , Polimorfismo de Nucleotídeo Único/genética , Proteína de Ligação a Vitamina D/genética , Alelos , Índice de Massa Corporal , Estudos de Casos e Controles , Feminino , Genótipo , Humanos , Pessoa de Meia-Idade , Risco , Fatores de Risco , Circunferência da Cintura/genética
20.
Turk J Gastroenterol ; 30(7): 611-615, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31290748

RESUMO

BACKGROUND/AIMS: This study investigated an association between obesity and impaired renal functions in elderly patients with nonalcoholic fatty liver disease (NAFLD) and evaluated the risk factors for chronic kidney disease (CKD) in these patients. MATERIALS AND METHODS: A cross-sectional study was performed involving 515 elderly patients (≥ 60 years old) with NAFLD. Demographics, body mass index (BMI), medical history, and laboratory parameters were compared for groups stratified by obesity (≥ 28 kg/m2) or CKD. An association between obesity and CKD was analyzed, and a multivariate logistic regression analysis was conducted for risk factors associated with CKD. RESULTS: In the overall population, 28.7% were obese and 54.8% had CKD; there were more women (58.8%) than men. The prevalence of hypertension and diabetes was similar between the obese and nonobese groups and between the CKD and non-CKD groups. Obese patients had significantly higher levels of serum uric acid and estimated glomerular filtration rates when compared with the nonobese group. When compared with those without CKD, patients with CKD were significantly older in addition to having higher BMI and serum uric acid levels. The multivariate logistic regression analysis indicated that CKD was positively associated with age, BMI, and serum uric acid levels. CONCLUSION: Elderly obese patients with NAFLD are at a higher risk of CKD. NAFLD patients with advanced age, greater BMI, or higher serum uric acid levels are more prone to developing CKD. The renal function of NAFLD patients should be closely monitored.


Assuntos
Hepatopatia Gordurosa não Alcoólica/complicações , Obesidade/complicações , Insuficiência Renal Crônica/etiologia , Fatores Etários , Idoso , Biomarcadores/sangue , Índice de Massa Corporal , Estudos Transversais , Feminino , Humanos , Testes de Função Renal , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Fatores Sexuais , Ácido Úrico/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA